ECLIPSE THERAPEUTICS

eclipse-therapeutics-logo

Eclipse Therapeutics, Inc. ("Eclipse") is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells (CSCs) and other forms of innovative cancer treatment.

#SimilarOrganizations #People #Financial #Website #More

ECLIPSE THERAPEUTICS

Social Links:

Industry:
Biotechnology

Founded:
2011-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.eclipsetherapeutics.com

Status:
Active

Email Addresses:
[email protected]

Total Funding:
2.78 M USD

Technology used in webpage:
SPF Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Apache ASP.NET IIS IIS 8 ASP.NET MVC


Similar Organizations

raze-therapeutics-logo

Raze Therapeutics

Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.

retrovirox-logo

RetroVirox

RetroVirox is a privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases

theracrine-logo

Theracrine

Theracrine Inc. is a private biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging

Founder


christopher-reyes_image

Christopher Reyes

Investors List

city-hill-ventures_image

City Hill Ventures

City Hill Ventures investment in Seed Round - Eclipse Therapeutics

Official Site Inspections

http://www.eclipsetherapeutics.com

  • Host name: ip-143-95-70-73.iplocal
  • IP address: 143.95.70.73
  • Location: Los Angeles United States
  • Latitude: 34.0549
  • Longitude: -118.2578
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90014

Loading ...

More informations about "Eclipse Therapeutics"

Aclipse Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Aclipse Therapeutics is a biopharmaceutical company that focuses on developing differentiated drugs to address diseases with unmet medical needs. Its strategy is reducing clinical โ€ฆSee details»

Eclipse Therapeutics - Crunchbase Company Profile & Funding

Eclipse Therapeutics, Inc. ("Eclipse") is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells (CSCs) and other โ€ฆSee details»

Aclipse Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...

Explore Aclipse Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Nervous System Diseases, Endocrinology and Metabolic Disease, โ€ฆSee details»

Aclipse Therapeutics - LinkedIn

Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by ...See details»

Eclipse Therapeutics Inc - Company Profile and News

Company profile page for Eclipse Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»

Aclipse Therapeutics Company Profile | Management and

[email protected]: Aclipse Therapeutics Top Competitors. Company Employees Revenue Top technologies; Collaborative Medicinal Development LLC. 10: $4.4 M: CuraSen โ€ฆSee details»

Aclipse Therapeutics - PitchBook

Www.aclipsetherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 170 North Radnor Chester Road; Suite 350; โ€ฆSee details»

Eclipse Therapeutics, Inc. Company Profile | San Diego, CA ...

Find company research, competitor information, contact details & financial data for Eclipse Therapeutics, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

Therapeutics - Aclipse Therapeutics

Therapeutics for Challenging Diseases M107 M102 Pipeline Indications for M102 Weโ€™re here to answer any questions. Looking to connect with us? CONTACT USSee details»

Aclipse Therapeutics Expands Drug Development Pipeline

Sep 14, 2023 [email protected] +1-412-606-7214. Prev Aclipse Therapeutics Announces Publication in Nature Reviews Drug Discovery of an Amyotrophic Lateral Sclerosis โ€ฆSee details»

Aclipse Therapeutics LLC - 82EF1 Details - GovTribe

Aclipse Therapeutics LLC - 82EF1 Federal Contract and Grant Award History. 82EF1. Partnership or Limited Liability Partnership. For Profit OrganizationSee details»

Aclipse Therapeutics | Raymond K. Houck | Treatment for ...

Www.aclipsetherapeutics.com. Contact: Raymond K. Houck, CEO. Aclipse Therapeutics. 170 N. Radnor Chester Rd., Suite 350. Radnor, PA 19087 USA ... One needs to understand the โ€ฆSee details»

Aclipse Therapeutics - Overview, News & Similar companies

Apr 20, 2022 Aclipse Therapeutics contact info: Phone number: (412) 606-7214 Website: www.aclipsetherapeutics.com What does Aclipse Therapeutics do? Aclipse Therapeutics is an โ€ฆSee details»

Aclipse Therapeutics: Contact Details and Business Profile

Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by โ€ฆSee details»

Aclipse Therapeutics LLC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Aclipse Therapeutics LLC of King OF Prussia, PA. Get the latest business insights from Dun & โ€ฆSee details»

Aclipse Therapeutics - Craft

Aclipse Therapeutics has 5 employees at their 1 location and $1 m in total funding,. See insights on Aclipse Therapeutics including office locations, competitors, revenue, financials, โ€ฆSee details»

Press Release Archives - Aclipse Therapeutics

Nov 10, 2024 For more information about Aclipse Therapeutics, visit the website at https://www.aclipsetherapeutics.com or email [email protected]. Contacts โ€ฆSee details»

Eclipse Therapeutics - PitchBook

Eclipse Therapeutics General Information Description. Provider of biotechnology platform that is focused on developing novel therapeutic product. The company's technology target cancer โ€ฆSee details»

Aclipse Therapeutics receives a therapeutic development award of โ€ฆ

Apr 20, 2022 Aclipse Therapeutics and its subsidiary Aclipse One Inc (โ€œAclipseโ€ or โ€œthe Companyโ€), an innovative biopharmaceutical company, today announced that the Company โ€ฆSee details»

linkstock.net © 2022. All rights reserved